2020 ASCO Virtual Direct™ Highlights

 

Avatar

2020 ASCO Update on Platinum Sensitive, Relapsed Ovarian Cancer: Is There an OS Benefit With Maintenance PARPi?

By Total Health 1201 Videos FEATURING Carolyn Muller
339 views
October 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin
GYN
19:19
Total Health

2020 ASCO Update on Recurrent Ovarian Cancer: Does Secondary Cytored…

Feat. C. Muller
07:40
Total Health

2020 ASCO Update on Platinum Sensitive, Relapsed Ovarian Cancer: Is …

Feat. C. Muller
09:08
Total Health

PARPi Efficacy in Recurrent Platinum Sensitive Ovarian Cancer: Is Ol…

Feat. C. Muller